Joint Osake

Joint EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Joint (JYNT) 1.8.2026 päivämäärällä on 738 722,00 USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −517 625,00 USD — muutos −242,71 % (korkeampi).

EBITDA

738 722,00USD

YoY

−242,71%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Joint on 2026 738 722,00 USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Joint oli 2025 −517 625,00 USD. Se laskee −242,71% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Joint Osakeanalyysi

Mitä Joint tekee? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Joint osakkeesta

Yhtiön Joint EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 738 722,00 USD vuonna 2026.

Access this data via the Eulerpool API

Tuloslaskelma — Joint

Kaikki tunnusluvut — Joint